Biosimilars, Control Towers & Boston Scientific's Pivot
Supply Chain Pulse — 2026-07-30
Bipartisan biosimilars legislation cleared both the House Energy and Commerce Committee and Senate HELP Committee this week — a rare show of congressional unity that could meaningfully expand GPO contracting options and drive down drug spend for your formulary. Pair that with new Black Book research showing health systems are redirecting 2027 budgets toward supply chain control towers and outcome-based managed services, and a clear theme emerges: the industry is done improvising and ready to invest in structural resilience. Meanwhile, Boston Scientific's simultaneous Q2 beat and global restructuring announcement is the kind of news that quietly reshapes your med-device vendor landscape. Watch your BSC contracts closely — restructurings have a way of affecting product lines, lead times, and rep coverage before the press release dust settles.
Quick Hits
- Boston Scientific formally notified the Irish government of potential job cuts tied to its global restructuring — a signal the program has real geographic scope beyond U.S. operations. (RTÉ News)
- GE HealthCare's CFO departed unexpectedly last week even as the company reported higher-than-expected preliminary revenues — leadership instability at a key imaging supplier is worth monitoring. (Modern Healthcare)
Bipartisan Biosimilars Bills Advance in Both Chambers — GPOs Take Note
The House Energy and Commerce Committee and Senate HELP Committee both advanced bipartisan legislation this week aimed at expanding patient access to biosimilars, drawing praise from the Healthcare Supply Chain Association and its GPO members. For supply chain leaders, this is a meaningful signal: if these bills become law, expect broader formulary options, increased competitive pressure on reference biologics, and new contracting leverage for organizations that move early. Start reviewing your biologics spend now — the window to renegotiate ahead of biosimilar market expansion may be shorter than you think.
Source: Healthcare Supply Chain Association (HSCA)
Black Book: 2027 Budgets Pivoting to Supply Chain Control Towers and Outcome-Based Managed Services
New Black Book research finds that health system supply chain budgets for 2027 are shifting decisively toward control tower technology and outcome-based managed services — a sign that point-solution fatigue is real and enterprise visibility is finally getting funded. The shift toward outcome-based contracts also signals that C-suites want vendors accountable for results, not just deliverables. If you're building your 2027 budget case right now, this data is your executive-level tailwind.
Source: GDELT - Healthcare Supply Chain
Boston Scientific Beats Q2 but Trims 2026 Outlook and Announces Global Restructuring
Boston Scientific posted strong Q2 results but simultaneously lowered its full-year 2026 guidance and unveiled a global restructuring program that includes job cuts — a combination that suggests tariff headwinds and margin pressure are biting even the strongest performers. For supply chain managers, restructurings at major med-device manufacturers can translate into SKU rationalization, longer lead times, or shifts in distribution partnerships. Now is the time to validate your BSC product availability commitments and flag any sole-source dependencies to your value analysis team.
Source: Medical Device Network
GE HealthCare Posts Record Orders, Weighs Sale of Patient Care Division
GE HealthCare reported record order growth in Q2 but disclosed it is actively reviewing whether to divest its patient care business — the unit covering monitoring and anesthesia products — either in whole or in part. For hospitals and ASCs, a potential sale of GE's monitoring and anesthesia portfolio could mean a change in service contracts, support infrastructure, and long-term parts availability. If GE HealthCare equipment is core to your OR or ICU, it's worth opening a conversation with your rep about continuity commitments.
Intermountain Health and AdventHealth to Form 8-Hospital Denver Joint Venture
Intermountain Health and AdventHealth have announced plans to combine their Denver-area operations into a joint venture spanning 8 hospitals, related facilities, and physician practices. Consolidations of this scale typically trigger supply chain integration projects — contract renegotiations, GPO alignment, and inventory standardization — that ripple out to vendors and distributors across the region. If you supply either system in Colorado, expect RFP activity and potential contract resets on the horizon.
Transparency, Prior Authorization, and PBM Reform Bills Clear Key Hurdles in Congress
A slate of health legislation targeting insurer transparency, prior authorization timelines, and pharmacy benefit manager practices has advanced with broad bipartisan support, giving each measure a strong chance of becoming law. PBM reform in particular could reshape how drug pricing flows through your pharmacy supply chain, potentially opening new negotiating dynamics for hospital pharmacies and closed-door dispensing operations. This is one to track closely with your pharmacy director — the downstream contracting implications could be significant.
You're receiving this because you subscribed to Supply Chain Pulse, a daily brief for healthcare supply chain professionals. Unsubscribe